Fig. 5: Changes in metabolic-associated genes and enzymes in the liver.
From: Non-insulin determinant pathways maintain glucose homeostasis upon metabolic surgery
a Expression levels of enriched glycolysis/gluconeogenesis and fatty acid metabolism pathway genes in the livers of sham and RYGB rats (n = 3). b, c Immunoblots of GCK, PFKL, PKLR, PDH, PDHK1 and β-actin in the liver from sham and RYGB rats (n = 6). d, e Immunoblots of p-ACC, t-ACC, CPT1 and β-actin in the liver from sham and RYGB rats (n = 6). f, g Immunoblots of PPARα, PPARβ, PPARδ, p-AMPK, AMPK, p-Akt, Akt and β-actin in the liver from sham and RYGB rats (n = 6). Values are shown as the mean ± s.e.m. Significance was calculated using a two-tailed unpaired t-test (c, e and g). *P < 0.05 and **P < 0.01 compared with the sham group
